Agencies Balk at Report on Diversity

WASHINGTON—Federal research administrators have reacted coolly to suggestions from the Congressional Office of Technology Assessment that their agencies become more active in support of programs to preserve biological diversity. In a lengthy report released in late March, OTA pressed Congress to increase funding to existing programs that foster or protect biological diversity, such as the Endangered Species Program and the National Plant Germplasm System. In addition, OTA proposed a specif

Written byNancy Heneson
| 3 min read

Register for free to listen to this article
Listen with Speechify
0:00
3:00
Share

In a lengthy report released in late March, OTA pressed Congress to increase funding to existing programs that foster or protect biological diversity, such as the Endangered Species Program and the National Plant Germplasm System. In addition, OTA proposed a specific niche for conservation biology within the National Science Foundation, cautioning in the same breath that NSF would probably argue that it conflicted with its mission as the nation's funder of basic research.

OTA correctly predicted resistance, but for the wrong reason. Frank Harris, NSF's deputy director of Biotic Systems and Resources, said the Foundation is already funding 90 percent of the research that falls under the loosely defined term "conservation biology." A separate program with sheltered money, he said, would take resources away from other parts of NSF's research budget without necessarily being more effective than the present system of funding projects in ecology, population biology, systematics and ecosystem ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
Image of a man in a laboratory looking frustrated with his failed experiment.
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies